Voyager Therapeutics (VYGR) Prepaid Assets (2014 - 2026)
Voyager Therapeutics' (VYGR) quarterly Prepaid Assets came in at $3.9 million in Q1 2026, down 45.5% year-on-year from $7.1 million in Q1 2025, and down 10.88% quarter-over-quarter from $4.3 million in Q4 2025.
Voyager Therapeutics (VYGR) Prepaid Assets (2014 - 2026) Analysis & Trends
Voyager Therapeutics has disclosed Prepaid Assets across 13 years of filings, most recently posting $3.9 million for Q1 2026.
- Prepaid Assets for Q1 2026 came in at $3.9 million, down 45.5% year-over-year; the trailing twelve-month figure through Mar 2026 was $3.9 million (down 45.5% YoY), and the FY2025 annual result was $4.3 million, down 45.53% from the prior year.
- Prepaid Assets came in at $3.9 million for Q1 2026 at Voyager Therapeutics, down from $4.3 million in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $9.8 million in Q2 2025 to a low of $696000.0 in Q4 2022.
- The 5-year median for Prepaid Assets is $5.7 million (2023), against an average of $5.5 million.
- Across the five-year window, Prepaid Assets plunged 79.69% in 2022 and surged 277.59% in 2023, its largest moves.
- Voyager Therapeutics' Prepaid Assets stood at $696000.0 in 2022, then soared by 277.59% to $2.6 million in 2023, then jumped by 202.32% to $7.9 million in 2024, then tumbled by 45.53% to $4.3 million in 2025, then dropped by 10.88% to $3.9 million in 2026.
- The last three Prepaid Assets figures came in at $3.9 million (Q1 2026), $4.3 million (Q4 2025), and $6.6 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Voyager Therapeutics | 222.52 Mn | 81.04 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.86 Mn |
| Dec 31, 2025 | 4.33 Mn |
| Sep 30, 2025 | 6.62 Mn |
| Jun 30, 2025 | 9.77 Mn |
| Mar 31, 2025 | 7.08 Mn |
| Dec 31, 2024 | 7.95 Mn |
| Sep 30, 2024 | 8.42 Mn |
| Jun 30, 2024 | 7.30 Mn |
| Mar 31, 2024 | 6.11 Mn |
| Dec 31, 2023 | 2.63 Mn |
| Sep 30, 2023 | 5.74 Mn |
| Jun 30, 2023 | 6.08 Mn |
| Mar 31, 2023 | 3.98 Mn |
| Dec 31, 2022 | 696,000.00 |
| Sep 30, 2022 | 5.08 Mn |
| Jun 30, 2022 | 3.42 Mn |
| Mar 31, 2022 | 3.61 Mn |
| Dec 31, 2021 | 3.43 Mn |
| Sep 30, 2021 | 3.54 Mn |
| Jun 30, 2021 | 3.91 Mn |